However, the review rated the overall evidence quality as very low due to small sample sizes, short follow-up periods, high risk of bias, and predominantly manufacturer-funded studies
However, higher TMAO was not associated with determined inflammatory [16] nor oxidative stress [17] markers
Commonly used GLP-1 drugs Here are some of the most common GLP-1 medications used for blood sugar and weight management
Tirzepatide expanded indications: Following FDA approvals in 20242025, tirzepatide (Zepbound/Mounjaro) has expanded labeling covering additional cardiovascular and metabolic indications
Inhibitors of PI3K and p42/44 mitogen-activated protein kinase (LY294002 and UO126), respectively as well as of p70S6K rapamycin abolished the GLP-1-induced infarct size limitation in rat hearts, suggesting that PI3K and p42/44 are involved in the myocardial protection elicited by GLP-1 [27, 69]